Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-03-08
DOI
10.1111/all.15271
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Considerations in boosting COVID-19 vaccine immune responses
- (2021) Philip R Krause et al. LANCET
- Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
- (2021) Madhumita Shrotri et al. LANCET
- Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
- (2021) Zhangkai Jason Cheng et al. Vaccines
- Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
- (2021) Yunlong Cao et al. CELL RESEARCH
- Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
- (2021) Gang Zeng et al. LANCET INFECTIOUS DISEASES
- Protection against Covid-19 by BNT162b2 Booster across Age Groups
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
- (2021) Barak Mizrahi et al. Nature Communications
- COVID-19 vaccine boosters: What do we know so far?
- (2021) Yousra Kherabi et al. Anaesthesia Critical Care & Pain Medicine
- 2019 Novel coronavirus: where we are and what we know
- (2020) Zhangkai J. Cheng et al. INFECTION
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started